The Oncology Institute, Inc. TOI Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s finance lease liabilities?
- The Oncology Institute, Inc. (TOI) reported finance lease liabilities of $19K in Q1 2026.
- How has The Oncology Institute, Inc.'s finance lease liabilities changed year-over-year?
- The Oncology Institute, Inc.'s finance lease liabilities decreased by 65.5% year-over-year, from $55K to $19K.
- What is the long-term trend for The Oncology Institute, Inc.'s finance lease liabilities?
- Over 3 years (2022 to 2025), The Oncology Institute, Inc.'s finance lease liabilities has grown at a -45.1% compound annual growth rate (CAGR), from $169K to $28K.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.